National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 279230

Case Details

VAERS ID: 279230 (history)  
Age: 21.0  
Gender: Female  
Location: California  
Vaccinated:2007-02-20
Onset:2007-02-20
   Days after vaccination:0
Submitted: 2007-05-14
   Days after onset:82
Entered: 2007-05-17
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0689F / 0 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Pruritus generalised
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: hormonal contraceptives
Current Illness:
Preexisting Conditions: None
Diagnostic Lab Data: None
CDC Split Type: WAES0704USA03189

Write-up: Information has been received from a physician''s assistant (PA), concerning a 21 year old female patient, who on 20-FEB-2007 was vaccinated with the first dose of Gardasil (Lot #653736/0689F). Concomitant therapy included hormonal contraceptives (unspecified). On 20-FEB-2007, following the vaccination, the patient experienced itching from head to toe for 3-4 days, but no rash was present. Treatment involved Benadryl. On approximately 24-FEB-2007 (after "3-4 days"), the patient recovered. The PA felt that the itching was "from the vaccination" and related to therapy with Gardasil. Additional information has been requested. Follow up information confirmed that the patient was vaccinated with the second dose of GARDASIL (date not specified), with no problems reported. No further information is expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=279230


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166